Peloso Paul 4

4 · ACELYRIN, Inc. · Filed May 11, 2023

Form 4

Period: 2023-05-09

Chief Medical Officer

Transactions

Purchase
Common Stock
2023-05-09$18.00/sh+6,000$108,000→ 6,000 total
Other
Employee Stock Option (right to buy)
2023-05-09+173,681→ 173,681 total
Exercise: $0.77Exp: 2031-07-25→ Common Stock (173,681 underlying)
Other
Employee Stock Option (right to buy)
2023-05-09−156,500→ 0 total
Exercise: $4.04Exp: 2032-01-19→ Class A Common Stock (156,500 underlying)
Other
Employee Stock Option (right to buy)
2023-05-09+156,500→ 156,500 total
Exercise: $4.04Exp: 2032-01-19→ Common Stock (156,500 underlying)
Other
Employee Stock Option (right to buy)
2023-05-09−173,681→ 0 total
Exercise: $0.77Exp: 2031-07-25→ Class A Common Stock (173,681 underlying)
Other
Employee Stock Option (right to buy)
2023-05-09−187,988→ 0 total
Exercise: $5.88Exp: 2032-11-20→ Class A Common Stock (187,988 underlying)
Other
Employee Stock Option (right to buy)
2023-05-09+187,988→ 187,988 total
Exercise: $5.88Exp: 2032-11-20→ Common Stock (187,988 underlying)
Other
Employee Stock Option (right to buy)
2023-05-09−154,957→ 0 total
Exercise: $18.00Exp: 2033-05-03→ Class A Common Stock (154,957 underlying)
Other
Employee Stock Option (right to buy)
2023-05-09+154,957→ 154,957 total
Exercise: $18.00Exp: 2033-05-03→ Common Stock (154,957 underlying)

Footnotes (6)

[F1]Reflects shares purchased through a directed share program in the Issuer's initial public offering of Common Stock (the "IPO").
[F2]Each share of Class A Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the IPO.
[F3]1/4 of the shares subject to the option vested on May 16, 2022 and 1/48 of the shares subject to the option vests in equal monthly installments thereafter, subject to the Reporting Person's continued service.
[F4]1/4 of the shares subject to the option vested on January 20, 2023, and 1/48 of the shares subject to the option vest in equal monthly installments thereafter, subject to the Reporting Person's continued service.
[F5]1/4 of the shares subject to the option vest on November 17, 2023, and 1/48 of the shares subject to the option vests in equal monthly installments thereafter, subject to the Reporting Person's continued service.
[F6]1/4 of the shares subject to the option vest on May 4, 2024, and 1/48 of the shares subject to the option vest in equal monthly installments thereafter, subject to the Reporting Person's continued service.

Documents

1 file